MiR-122 modulates type i interferon expression through blocking suppressor of cytokine signaling 1

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 4, 2013, Pages 858-865

  Li, Aimei ^a,b   Song, Wuqi ^a,b   Qian, Jun ^a,b   Li, Yujun ^a,b   He, Junming ^a,b   Zhang, Qingmeng ^a,b   Li, Wenhui ^a,b   Zhai, Aixia ^a,b   Kao, Wenping ^a,b   Hu, Yunlong ^a,b   Li, Hui ^a,b   Wu, Jing ^a,b   Ling, Hong ^a,b   Zhong, Zhaohua ^a,b   Zhang, Fengmin ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Immunity and Infection Key Laboratory of Heilongjiang Province   (China)

Author keywords

Hepatocytes; MiR 122; MiRNA; Suppressor of cytokine signaling 1; Type I interferon

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; ENHANCED GREEN FLUORESCENT PROTEIN; INTERFERON; MESSENGER RNA; MICRORNA 122; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; INTERFERON PRODUCTION; LIVER; OLIGODENDROGLIA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

BASE SEQUENCE; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; MICRORNAS; RNA, MESSENGER; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

HEPATITIS C VIRUS;

EID: 84873699642     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.01.008     Document Type: Article

References (31)

1. D.S. Aaronson, and C.M. Horvath A road map for those who don't know JAK-STAT Science 296 2002 1653 1655
2. L. Alves Jr., S. Niemeier, A. Hauenschild, M. Rehmsmeier, and T. Merkle Comprehensive prediction of novel microRNA targets in Arabidopsis thaliana Nucleic Acids Research 37 2009 4010 4021
3. S. Bai, M.W. Nasser, B. Wang, S.H. Hsu, J. Datta, and H. Kutay MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib Journal of Biological Chemistry 284 2009 32015 32027
4. M.M. Brierley, and E.N. Fish Review IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry Journal of Interferon and Cytokine Research 22 2002 835 845
5. J. Chang, E. Nicolas, D. Marks, C. Sander, A. Lerro, and M.A. Buendia miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1 RNA Biology 1 2004 106 113
6. C. Coulouarn, V.M. Factor, J.B. Andersen, M.E. Durkin, and S.S. Thorgeirsson Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties Oncogene 28 2009 3526 3536
7. J.E. Darnell Jr., I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
8. C.G. Fan, C.M. Wang, C. Tian, Y. Wang, L. Li, and W.S. Sun miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3 Oncology Reports 26 2011 1281 1286
9. E. Fasler-Kan, A. Pansky, M. Wiederkehr, M. Battegay, and M.H. Heim Interferon-alpha activates signal transducers and activators of transcription 5 and 6 in Daudi cells European Journal of Biochemistry 254 1998 514 519
10. J.E. Fenner, R. Starr, A.L. Cornish, J.G. Zhang, D. Metcalf, and R.D. Schreiber Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity Nature Immunology 7 2006 33 39
11. Girard, M. Jacquemin, E. Munnich, A. Lyonnet, and S. Henrion-Caude A. miR-122, a paradigm for the role of microRNAs in the liver Journal of Hepatology 48 2008 648 656
12. L. Gramantieri, M. Ferracin, F. Fornari, A. Veronese, S. Sabbioni, and C.G. Liu Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma Cancer Research 67 2007 6092 6099
13. I. Gresser, and F. Belardelli Endogenous type I interferons as a defense against tumors Cytokine and Growth Factor Reviews 13 2002 111 118
14. K. Herzer, T.G. Hofmann, A. Teufel, C.C. Schimanski, M. Moehler, and S. Kanzler IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53 Cancer Research 69 2009 855 862
15. K. Imanaka, S. Tamura, K. Fukui, N. Ito, S. Kiso, and Y. Imai Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy Journal of Viral Hepatitis 12 2005 130 138
16. C.L. Jopling, M. Yi, A.M. Lancaster, S.M. Lemon, and P. Sarnow Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA Science 309 2005 1577 1581
17. A.P. Lewis, and C.L. Jopling Regulation and biological function of the liver-specific miR-122 Biochemical Society Transactions 38 2010 1553 1557
18. C.J. Lin, H.Y. Gong, H.C. Tseng, W.L. Wang, and J.L. Wu miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines Biochemical and Biophysical Research Communications 375 2008 315 320
19. J.P. Liu, Y.L. Wang X, J.L. Li, and W.Z. Ho Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes Transplant Infectious Disease 13 2011 24 32
20. L. Ma, J. Liu, J. Shen, L. Liu, J. Wu, and W. Li Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells Cancer Biology and Therapy 9 2010 554 561
21. A. Meinke, F. Barahmand-Pour, S. Wohrl, D. Stoiber, and T. Decker Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons Molecular and Cellular Biology 16 1996 6937 6944
22. S. Parmar, and L.C. Platanias Interferons: mechanisms of action and clinical applications Current Opinion in Oncology 15 2003 431 439
23. L.M. Pfeffer, M.A. Madey, C.A. Riely, and J.F. Fleckenstein The induction of type I interferon production in hepatitis C-infected patients Journal of Interferon and Cytokine Research 29 2009 299 306
24. J. Qian, A. Zhai, W. Kao, Y. Li, W. Song, and Y. Fu Modulation of miR-122 on persistently Borna disease virus infected human oligodendroglial cells Antiviral Research 87 2010 249 256
25. N. Rajewsky microRNA target predictions in animals Nature Genetics 38 Suppl. 2006 S8 S13
26. M. Sarasin-Filipowicz, J. Krol, I. Markiewicz, M.H. Heim, and W. Filipowicz Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy Nature Medicine 15 2009 31 33
27. A. Takaoka, S. Hayakawa, H. Yanai, D. Stoiber, H. Negishi, and H. Kikuchi Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence Nature 424 2003 516 523
28. N. Torpey, S.E. Maher, A.L. Bothwell, and J.S. Pober Interferon alpha but not interleukin 12 activates STAT4 signaling in human vascular endothelial cells Journal of Biological Chemistry 279 2004 26789 26796
29. W.C. Tsai, P.W. Hsu, T.C. Lai, G.Y. Chau, C.W. Lin, and C.M. Chen MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma Hepatology 49 2009 1571 1582
30. L. Valentino, and J. Pierre JAK/STAT signal transduction: regulators and implication in hematological malignancies Biochemical Pharmacology 71 2006 713 721
31. G. Zhang, Q. Wang, and R. Xu Therapeutics based on microRNA: a new approach for liver cancer Current Genomics 11 2010 311 325